Loading...
NPI 1104199413 · Sun City, AZ · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Barnet Dulaney Perkins Eye Center, PC is a ambulatory surgical clinic/center provider located in Sun City, Arizona. This profile covers 22 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Barnet Dulaney Perkins Eye Center, PC |
| Address | 14820 N Del Webb Blvd |
| City | Sun City |
| State | AZ |
| ZIP | 85351 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | February 16, 2012 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.8M |
| Medicaid | $1.1M |
BARNET DULANEY PERKINS EYE CENTER, PC presents as an ambulatory surgical ophthalmology-focused practice: the Medicare and Medicaid code mix is dominated by cataract surgery (66984) and high-volume intraocular/steroid insert usage (J1096 and J1095), with additional retina and oculoplastics procedures present. The top Medicare codes and Medicaid codes align with an ASC-style workload that combines operative cataract care with substantial in‑office pharmacologic management and some vitreoretinal capability (e.g., 67036, 67041).
Medicaid revenue is heavily concentrated in the same small set of therapies: the provider reports $1.1M total Medicaid revenue and the precomputed top-3 Medicaid codes account for 99.0% of this provider's total Medicaid revenue, with 66984 at $756.4K (66.2%), J1096 at $206.2K (18.0%), and J1095 at $169.2K (14.8%).
Payer mix shows Medicare scale exceeds Medicaid scale but both are material: Medicare revenue ($2.8M) is larger than Medicaid revenue ($1.1M), indicating the practice serves a mixed payer population but derives the majority of its billed revenue from Medicare. The coexistence of substantial Medicaid billing—especially concentrated in the same intraocular drug and cataract codes—suggests similar service lines are billed across payers rather than a distinct payer-specific service mix.
Competitive standing is asymmetric by code and payer. For Medicare the practice’s J1096 volume ranks #4 of 282 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code), and 66821 ranks #138 of 10087 (99th percentile; notably above typical national volume), while 66984 sits at #1414 of 15965 (91th percentile; typical, unremarkable volume). For Medicaid the provider is a statewide leader on intraocular steroids—J1096 ranks #1 of 10 providers in-state (100th percentile; notably above typical state volume) and J1095 ranks #1 of 13 in-state (100th percentile; notably above typical state volume)—while 66984 is also high in-state at #12 of 75 (85th percentile; typical, unremarkable volume).
Presence of high-volume intraocular steroid codes (J1096 nationally extreme outlier on Medicare; J1096 and J1095 rank #1 in-state for Medicaid) signals an operational emphasis on sustained-release/injectable pharmacologic care alongside surgery. This pattern—high usage of J1096/J1095 paired with large cataract volumes (66984)—is consistent with an integrated model that performs many cataract procedures and administers adjunct intraocular steroid therapy perioperatively or in clinic.
There are additional notable outliers in the Medicare mix beyond cataract and inserts: 65855 appears as an extreme outlier nationally (206 claims; ranks #45 of 2796 providers nationally, 98th percentile; extreme outlier, far above typical national volume), indicating the provider also performs a relatively large number of selective laser trabeculoplasty procedures compared with peers. These elevated procedure-level percentiles suggest the practice’s scope extends into glaucoma laser management in addition to cataract and intraocular drug delivery.
The provider has an established tenure in the dataset, with NPI enumeration on 2012-02-16 (~14 years ago), supporting that observed billing patterns reflect a multi-year operating profile rather than a short-term reporting spike. Given sustained, concentrated revenue in a narrow set of ophthalmic surgical and intraocular drug codes across both payers, analysts should treat this as a mature ASC-level ophthalmology practice with specialized pharmacologic throughput when assessing network capacity or competitive positioning.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
22 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 1,560 | $820 | $1.3M |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 5,880 | $100 | $581.7K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 740 | $200 | $146.7K |
| 65820 | The provider incises the limbus to improve drainage of aqueous humor in the eye. This procedure is typically performed on children, usually to treat congenital glaucoma. | 90 | $1,500 | $130.1K |
| 66991 | The provider inserts an intraocular lens prosthesis during the same session as extracapsular cataract extraction. The provider also inserts one or more anterior segment aqueous drainage devices in… | 40 | $2,530 | $98.8K |
| 67036 | The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana. | 60 | $1,520 | $90.9K |
| 15823 | In this procedure, the provider surgically trims excessive skin that weighs down the upper eyelid, typically to improve the cosmetic appearance of the face and due to the interference of the tissue… | 150 | $510 | $74K |
| 66174 | The provider expands the aqueous outflow (drainage) canal of the eye to help relieve pressure in the eye. The procedure does not include leaving a device or stent in place. | 60 | $1,130 | $72.1K |
| 66982 | The provider inserts an intraocular lens prosthesis after extracapsular cataract extraction using complex techniques and devices. He may perform this by means of an iris expansion device, providing… | 90 | $760 | $71.8K |
| V2785 | Processing, preserving and transporting corneal tissue | 20 | $3,750 | $56.2K |
Showing 1–10 of 22
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
22 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J1096 | 1 | 20 | 1,430 | $100 | $167.4K |
| 66984 | 6 | 270 | 150 | $580 | $159.7K |
| V2785 | 7 | 10 | 30 | $3,500 | $146.8K |
| J1097 | 9 | 10 | 510 | $80 | $58.7K |
| 66991 | 20 | 60 | 30 | $1,540 | $56.9K |
| 67041 | 8 | 20 | 30 | $1,220 | $51K |
| 15823 | 7 | 40 | 50 | $520 | $49.9K |
| 66174 | 9 | 30 | 40 | $840 | $43.5K |
| 65820 | 2 | 20 | 30 | $970 | $40.9K |
| 67036 | 4 | 30 | 30 | $1,030 | $37.9K |
Showing 1–10 of 22
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 2,030 | $370 | $756.4K |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 950 | $220 | $206.2K |
| J1095 | Injection, dexamethasone 9 percent, intraocular, 1 microgram | 710 | $240 | $169.2K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 160 | $70 | $11.2K |
How this provider's Medicaid billing volume and revenue compare to other Arizona providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arizona median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 12 | 80 | 390 | $330 | $311.6K |
| J1095 | Injection, dexamethasone 9 percent, intraocular, 1 microgram | 1 | 10 | 290 | $250 | $82.4K |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 1 | 10 | 320 | $220 | $82.2K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 9 | 20 | 90 | $100 | $22.8K |
Other providers in the same ZIP code as Barnet Dulaney Perkins Eye Center, PC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.